# Effects of Desoximetasone Spray 0.25% on Moderate to Severe Plaque Psoriasis

> **NCT01206387** · PHASE3 · COMPLETED · sponsor: **Sun Pharmaceutical Industries, Inc.** · enrollment: 120 (actual)

## Conditions studied

- Psoriasis

## Interventions

- **DRUG:** Desoximetasone Spray 0.25%
- **DRUG:** placebo comparator

## Key facts

- **NCT ID:** NCT01206387
- **Lead sponsor:** Sun Pharmaceutical Industries, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-08
- **Primary completion:** 2010-12
- **Final completion:** 2011-01
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2017-06-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01206387

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01206387, "Effects of Desoximetasone Spray 0.25% on Moderate to Severe Plaque Psoriasis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01206387. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*